Relief Therapeutics Holding Stock Probability of Future OTC Stock Price Finishing Over 5.6

RLFTF Stock  USD 4.29  0.04  0.94%   
Relief Therapeutics' future price is the expected price of Relief Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Relief Therapeutics Holding performance during a given time horizon utilizing its historical volatility. Check out Relief Therapeutics Backtesting, Relief Therapeutics Valuation, Relief Therapeutics Correlation, Relief Therapeutics Hype Analysis, Relief Therapeutics Volatility, Relief Therapeutics History as well as Relief Therapeutics Performance.
  
Please specify Relief Therapeutics' target price for which you would like Relief Therapeutics odds to be computed.

Relief Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Relief Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Relief Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Relief Therapeutics is way too risky over 90 days horizon
Relief Therapeutics appears to be risky and price may revert if volatility continues
The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M.
Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Relief Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Relief OTC Stock often depends not only on the future outlook of the current and potential Relief Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relief Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.1 B

Relief Therapeutics Technical Analysis

Relief Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Relief OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Relief Therapeutics Holding. In general, you should focus on analyzing Relief OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Relief Therapeutics Predictive Forecast Models

Relief Therapeutics' time-series forecasting models is one of many Relief Therapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Relief Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Relief Therapeutics

Checking the ongoing alerts about Relief Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Relief Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Relief Therapeutics is way too risky over 90 days horizon
Relief Therapeutics appears to be risky and price may revert if volatility continues
The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M.
Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Other Information on Investing in Relief OTC Stock

Relief Therapeutics financial ratios help investors to determine whether Relief OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Relief with respect to the benefits of owning Relief Therapeutics security.